Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

NCT01921855 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A
Hemophilia B

Interventions

DRUG: BAY Factor VII (BAY86-6150)
DRUG: BAY Factor VII (BAY86-6150)
DRUG: BAY Factor VII (BAY86-6150)
DRUG: BAY Factor VII (BAY86-6150)
DRUG: Placebo

Sponsor

Bayer